Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Everett Meyer

T-cell monitoring and immunotherapy for treating graft-versus-host disease

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Corey Casper

Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa

Non-Hodgkin lymphoma

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies

Wing Leung

KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN

Leukaemia

Pediatric oncology or childhood cancer

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies